Gene–gene interaction of erythropoietin gene polymorphisms and diabetic retinopathy in Chinese Han

Experimental Biology and Medicine

Volumn 241, Issue 14, 2016, Pages 1524-1530

  Fan, YanFei ^a   Fu, Yin Yu ^a   Chen, Zhi ^a   Hu, Yuan Yuan ^a   Shen, Jie ^a  

^a THE THIRD AFFILIATED HOSPITAL OF SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Diabetic retinopathy; EPO; interaction; polymorphism

Indexed keywords

ERYTHROPOIETIN; GENOMIC DNA; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DNA POLYMORPHISM; FEMALE; GENE INTERACTION; GENE MUTATION; GLUCOSE BLOOD LEVEL; HUMAN; MACULAR EDEMA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PARESTHESIA; RETINA HEMORRHAGE; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; WAIST CIRCUMFERENCE; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CASE CONTROL STUDY; CHINA; GENETIC PREDISPOSITION; GENETICS; ODDS RATIO; STATISTICAL MODEL;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; DIABETIC RETINOPATHY; ERYTHROPOIETIN; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84980013170     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1177/1535370216645210     Document Type: Article

References (27)

1. R.KleinB.E.KleinS.E.MossM.D.DavisD.L.DeMets. The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol1984; 102: 527–32.
2. R.PradeepaJ.SurendarK.IndulekhaS.ChellaR.M.AnjanaV.Mohan. Relationship of diabetic retinopathy with coronary artery disease in Asian Indians with type 2 diabetes: The Chennai Urban Rural Epidemiology Study (CURES) Eye Study-3. Diab Technol Ther2015; 17: 112–8.
3. C.KarlbergC.FalkA.GreenA.K.SjolieJ.Grauslund. Proliferative retinopathy predicts nephropathy: a 25-year follow-up study of type 1 diabetic patients. Acta Diabetol2012; 49: 263–8.
4. K.HietalaC.ForsblomP.SummanenP.H.Groop. Heritability of proliferative diabetic retinopathy. Diabetes2008; 57: 2176–80.
5. H.C.LookerR.G.NelsonE.ChewH.C.LookerR.G.NelsonE.ChewR.KleinB.E.KleinW.C.KnowlerR.L.Hanson. Genome-wide linkage analyses to identify Loci for diabetic retinopathy. Diabetes2007; 56: 1160–6.
6. N.Ferrara. Vascular endothelial growth factor. The trigger for neovascularization in the eye. Lab Investigat; a journal of technical methods and pathology1995; 72: 615–8.
7. K.JaquetK.KrauseM.Tawakol-KhodaiS.GeidelK.H.Kuck. Erythropoietin and VEGF exhibit equal angiogenic potential. Microvasc Res2002; 64: 326–33.
8. T.CohenD.NahariL.W.CeremG.NeufeldB.Z.Levi. Interleukin 6 induces the expression of vascular endothelial growth factor. J Biological Chem1996; 271: 736–41.
9. H.P.HammesA.WeissS.HessN.ArakiS.HoriuchiM.BrownleeK.T.Preissner. Modification of vitronectin by advanced glycation alters functional properties in vitro and in the diabetic retina. Lab Investigat; a journal of technical methods and pathology1996; 75: 325–38.
10. D.WatanabeK.SuzumaS.MatsuiM.KurimotoJ.KiryuM.KitaI.SuzumaH.OhashiT.OjimaT.MurakamiT.KobayashiS.MasudaM.NagaoN.YoshimuraH.Takagi. Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy. N Engl J Med2005; 353: 782–92.
11. C.GrimmA.WenzelN.AcarS.KellerM.SeeligerM.Gassmann. Hypoxic preconditioning and erythropoietin protect retinal neurons from degeneration. Adv Exp Med Biol2006; 588: 119–31.
12. M.Garcıa-RamırezC.HernandezR.Simo. Expression of erythropoietin and its receptor in the human retina: a comparative study of diabetic and non- diabetic subjects. Diab Care2008; 31: 1189–94.
13. H.TakagiD.WatanabeK.Suzuma. Novel role of erythropoietin in proliferative diabetic retinopathy. Diab Res Clin Pract2007; 77: S62–4.
14. S.AbharyK.P.BurdonR.J.CassonM.GogginN.P.PetrovskyJ.E.Craig. Association between erythropoietin gene polymorphisms and diabetic retinopathy. Archive Ophthalmol2010; 128: 102–6.
15. Z.TongZ.YangS.PatelH.ChenD.GibbsX.YangV.S.HauY.KaminohJ.HarmonE.PearsonJ.BuehlerY.ChenB.YuN.H.TinkhamN.A.ZabriskieJ.ZengL.LuoJ.K.SunM.PrakashR.N.HamamS.TonnaR.ConstantineC.C.RonquilloS.SaddaR.L.AveryJ.M.BrandN.LondonA.L.AnduzeG.L.KingP.S.BernsteinS.WatkinsL.B.JordeD.Y.LiL.P.AielloM.R.PollakK.Zhang. Promoter polymorphism of the erythropoietin gene in severe diabetic eye and kidney complications. Proc Natl Acad Sci USA2008; 105: 6998–7003.
16. Q.SongY.ZhangY.WuF.ZhouY.Qu. Association of erythropoietin gene polymorphisms with retinopathy in a Chinese cohort with type 2 diabetes mellitus. Clin Exp Ophthalmol2015; 43: 544–9.
17. S.BalasubbuP.SundaresanA.RajendranK.RamasamyG.GovindarajanN.PerumalsamyJ.F.Hejtmancik. Association analysis of nine candidate gene polymorphisms in Indian patients with type 2 diabetic retinopathy. BMC Med Genet2010; 11: 158–158.
18. T.LohmanA.F.RocheR.Martorell. Standardization of anthropometric measurements, Champaign, IL: Human Kinetics, 1988.
19. S.AlwakeelA.Al-SuwaidaA.IsnaniA.Al-HarbiA.Alam. Concomitant macro and microvascular complications in diabetic nephropathy. Saudi J Kidney Dis Transplant2009; 20: 402–9.
20. X.Y.LouG.B.ChenL.YanJ.Z.MaJ.ZhuR.C.ElstonM.D.Li. A generalized combinatorial approach for detecting gene-by gene and gene-by- environment interactions with application to nicotine dependence. Am J Hum Genet2007; 80: 1125–37.
21. W.W.WilliamsR.M.SalemA.J.McKnightN.SandholmC.ForsblomA.TaylorC.GuiducciJ.B.McAteerG.J.McKayT.IsakovaE.P.BrennanD.M.SadlierC.PalmerJ.SöderlundE.FagerholmV.HarjutsaloR.LithoviusD.GordinK.HietalaJ.KytöM.ParkkonenM.Rosengård-BärlundL.ThornA.SyreeniN.TolonenM.SaraheimoJ.WadénJ.PitkäniemiC.SartiJ.TuomilehtoK.TryggvasonA.M.ÖsterholmB.HeS.BainF.MartinC.GodsonJ.N.HirschhornA.P.MaxwellP.H.GroopJ.C.Florez. GENIE Consortium. Association testing of previously reported variantsin a large case-control meta-analysis of diabetic nephropathy. Diabetes2012; 61: 2187–94.
22. S.M.HosseiniA.P.BorightL.SunA.J.CantyS.B.BullB.E.KleinR.KleinA.D.Paterson. DCCT/EDIC Research Group. The association of previously reported polymorphisms for microvascular complications in a meta-analysis of diabetic retinopathy. Hum Genet2015; 134: 247–57.
23. J.ChenK.M.ConnorC.M.AdermanK.L.WillettO.P.AspegrenL.E.Smith. Suppression of retinal neovascularization by erythropoietin siRNA in a mouse model of proliferative retinopathy. Invest Ophthalmol Vis Sci2009; 50: 1329–35.
24. R.YamajiT.OkadaM.MoriyaM.NaitoT.TsuruoK.MiyatakeY.Nakano. Brain capillary endothelial cells express two forms of erythropoietin receptor mRNA. Eur J Biochem1996; 239: 494–500.
25. A.AnagnostouE.S.LeeN.KessimianR.LevinsonM.Steiner. Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells. Proc Natl Acad Sci USA1990; 87: 5978–82.
26. Y.KatsuraT.OkanoK.MatsunoM.OsakoM.KureT.WatanabeY.IwakiM.NoritakeH.KosanoH.NishigoriT.Matsuoka. Erythropoietin is highly elevated in vitreous fluid of patients with proliferative diabetic retinopathy. Diab Care2005; 28: 2252–4.
27. W.LuoZ.GuoM.WuC.HaoX.HuZ.ZhouZ.ZhouX.YaoL.ZhangJ.Liu. Association of peroxisome proliferator-activated receptor α/δ/γ with obesity, and gene–gene interaction, in the Chinese Han population. J Epidemiol2013; 23: 187–94.